 Leslie Berg
Concepts (487)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein-Tyrosine Kinases | 60 | 2021 | 432 | 10.380 |
Why?
| | T-Lymphocytes | 45 | 2022 | 1928 | 4.150 |
Why?
| | Receptors, Antigen, T-Cell | 41 | 2024 | 704 | 4.000 |
Why?
| | CD8-Positive T-Lymphocytes | 22 | 2020 | 857 | 3.900 |
Why?
| | Signal Transduction | 51 | 2024 | 4925 | 3.340 |
Why?
| | Cell Differentiation | 41 | 2017 | 1902 | 3.320 |
Why?
| | Lymphocyte Activation | 32 | 2024 | 1106 | 3.180 |
Why?
| | CD4-Positive T-Lymphocytes | 25 | 2016 | 1056 | 2.570 |
Why?
| | Interferon Regulatory Factors | 5 | 2020 | 33 | 2.160 |
Why?
| | Lymphocytic choriomeningitis virus | 7 | 2017 | 24 | 2.010 |
Why?
| | Thymus Gland | 24 | 2014 | 306 | 1.840 |
Why?
| | Mice | 89 | 2022 | 16937 | 1.400 |
Why?
| | T-Lymphocyte Subsets | 13 | 2014 | 412 | 1.370 |
Why?
| | Mice, Knockout | 31 | 2020 | 2871 | 1.360 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 11 | 2017 | 336 | 1.260 |
Why?
| | Animals | 107 | 2024 | 35361 | 1.250 |
Why?
| | Janus Kinase 3 | 16 | 2009 | 18 | 1.130 |
Why?
| | Intestines | 3 | 2020 | 348 | 1.110 |
Why?
| | Lymphocytic Choriomeningitis | 4 | 2015 | 14 | 1.070 |
Why?
| | Lymphocytes | 5 | 2019 | 377 | 1.050 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 7 | 2014 | 100 | 1.010 |
Why?
| | Mice, Inbred C57BL | 40 | 2020 | 5440 | 1.000 |
Why?
| | Proto-Oncogene Proteins c-vav | 1 | 2024 | 2 | 0.920 |
Why?
| | Th1 Cells | 4 | 2015 | 138 | 0.920 |
Why?
| | T-Box Domain Proteins | 6 | 2015 | 96 | 0.880 |
Why?
| | Immunologic Memory | 8 | 2017 | 349 | 0.880 |
Why?
| | Mice, Transgenic | 32 | 2015 | 2119 | 0.840 |
Why?
| | Cell Proliferation | 7 | 2020 | 2391 | 0.810 |
Why?
| | Interleukin Receptor Common gamma Subunit | 3 | 2019 | 14 | 0.790 |
Why?
| | Chemotaxis, Leukocyte | 3 | 2020 | 137 | 0.790 |
Why?
| | Cells, Cultured | 16 | 2021 | 4083 | 0.770 |
Why?
| | Flow Cytometry | 15 | 2022 | 1156 | 0.720 |
Why?
| | Autoimmune Diseases | 2 | 2024 | 426 | 0.710 |
Why?
| | Arenaviridae Infections | 3 | 2017 | 8 | 0.700 |
Why?
| | CD4 Antigens | 9 | 2007 | 138 | 0.690 |
Why?
| | Calcium | 3 | 2022 | 1213 | 0.650 |
Why?
| | Transcription Factors | 11 | 2016 | 1651 | 0.610 |
Why?
| | Cytokines | 7 | 2009 | 2017 | 0.600 |
Why?
| | Killer Cells, Natural | 4 | 2014 | 427 | 0.580 |
Why?
| | Natural Killer T-Cells | 3 | 2014 | 65 | 0.580 |
Why?
| | Kruppel-Like Transcription Factors | 3 | 2014 | 67 | 0.570 |
Why?
| | Influenza A virus | 3 | 2016 | 100 | 0.570 |
Why?
| | Orthomyxoviridae Infections | 2 | 2016 | 67 | 0.560 |
Why?
| | Colitis | 2 | 2019 | 242 | 0.540 |
Why?
| | Interleukin-2 | 9 | 2019 | 436 | 0.520 |
Why?
| | Th2 Cells | 3 | 2009 | 171 | 0.520 |
Why?
| | Enhancer Elements, Genetic | 2 | 2017 | 177 | 0.510 |
Why?
| | Models, Immunological | 5 | 2012 | 95 | 0.460 |
Why?
| | Molecular Sequence Data | 20 | 2015 | 2832 | 0.460 |
Why?
| | Amino Acid Sequence | 19 | 2015 | 2058 | 0.460 |
Why?
| | Repressor Proteins | 1 | 2017 | 406 | 0.440 |
Why?
| | NFATC Transcription Factors | 6 | 2021 | 84 | 0.440 |
Why?
| | CD28 Antigens | 5 | 2013 | 48 | 0.430 |
Why?
| | Nuclear Proteins | 4 | 2003 | 663 | 0.430 |
Why?
| | Interferon-gamma | 6 | 2016 | 770 | 0.420 |
Why?
| | Inflammation | 1 | 2024 | 2736 | 0.420 |
Why?
| | Ephrins | 2 | 2002 | 8 | 0.410 |
Why?
| | Receptor-CD3 Complex, Antigen, T-Cell | 3 | 2001 | 9 | 0.410 |
Why?
| | Gene Expression Regulation | 7 | 2021 | 2548 | 0.410 |
Why?
| | Allergy and Immunology | 1 | 2012 | 43 | 0.390 |
Why?
| | Membrane Proteins | 4 | 2015 | 1119 | 0.390 |
Why?
| | Histocompatibility Antigens Class I | 4 | 2010 | 200 | 0.380 |
Why?
| | Antigens, CD | 6 | 2016 | 489 | 0.380 |
Why?
| | Protein Kinase Inhibitors | 2 | 2015 | 891 | 0.370 |
Why?
| | Phosphorylation | 11 | 2018 | 1713 | 0.370 |
Why?
| | Interleukin-4 | 5 | 2014 | 212 | 0.360 |
Why?
| | Cellular Senescence | 1 | 2013 | 181 | 0.360 |
Why?
| | Epigenesis, Genetic | 2 | 2013 | 613 | 0.360 |
Why?
| | Phospholipase C gamma | 5 | 2018 | 29 | 0.340 |
Why?
| | Thymocytes | 3 | 2014 | 33 | 0.320 |
Why?
| | Adoptive Transfer | 3 | 2020 | 218 | 0.320 |
Why?
| | Proto-Oncogene Proteins c-abl | 1 | 2008 | 6 | 0.310 |
Why?
| | X-Linked Combined Immunodeficiency Diseases | 1 | 2008 | 2 | 0.310 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2009 | 135 | 0.310 |
Why?
| | Apoptosis | 6 | 2014 | 2503 | 0.310 |
Why?
| | Major Histocompatibility Complex | 5 | 1997 | 230 | 0.310 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2013 | 372 | 0.290 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2019 | 139 | 0.290 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2010 | 231 | 0.290 |
Why?
| | Phosphoproteins | 2 | 2001 | 332 | 0.290 |
Why?
| | Interleukin-15 | 4 | 2014 | 82 | 0.290 |
Why?
| | src-Family Kinases | 3 | 2018 | 96 | 0.280 |
Why?
| | src Homology Domains | 5 | 2003 | 37 | 0.280 |
Why?
| | Immunoglobulin E | 1 | 2009 | 329 | 0.280 |
Why?
| | Cell Lineage | 7 | 2015 | 333 | 0.280 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2008 | 101 | 0.280 |
Why?
| | CD8 Antigens | 6 | 2007 | 76 | 0.280 |
Why?
| | Tyrosine | 4 | 2013 | 223 | 0.280 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 375 | 0.270 |
Why?
| | Cell Cycle | 1 | 2009 | 592 | 0.260 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 3 | 2014 | 6 | 0.260 |
Why?
| | Receptors, Eph Family | 2 | 2002 | 6 | 0.260 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2016 | 220 | 0.260 |
Why?
| | Antigens, Differentiation | 3 | 2004 | 81 | 0.250 |
Why?
| | Lymphopenia | 2 | 2008 | 59 | 0.250 |
Why?
| | B-Lymphocytes | 4 | 2009 | 815 | 0.250 |
Why?
| | Mast Cells | 1 | 2007 | 142 | 0.250 |
Why?
| | Humans | 37 | 2024 | 129650 | 0.240 |
Why?
| | Autoimmunity | 2 | 2024 | 862 | 0.230 |
Why?
| | Antigens, CD1d | 2 | 2014 | 66 | 0.230 |
Why?
| | Up-Regulation | 6 | 2014 | 840 | 0.220 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 958 | 0.220 |
Why?
| | Ligands | 8 | 2009 | 622 | 0.220 |
Why?
| | Gene Expression | 5 | 2014 | 1472 | 0.220 |
Why?
| | Enzyme Activation | 6 | 2010 | 811 | 0.210 |
Why?
| | Receptor, EphA1 | 1 | 2002 | 2 | 0.210 |
Why?
| | Receptors, Lymphocyte Homing | 2 | 2020 | 16 | 0.210 |
Why?
| | Homeostasis | 3 | 2013 | 611 | 0.200 |
Why?
| | Stomach Neoplasms | 1 | 2024 | 99 | 0.200 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 312 | 0.200 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2002 | 359 | 0.200 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 94 | 0.200 |
Why?
| | Membrane Glycoproteins | 2 | 2002 | 474 | 0.200 |
Why?
| | Interleukin-17 | 3 | 2013 | 108 | 0.200 |
Why?
| | Cytoplasm | 2 | 2022 | 263 | 0.200 |
Why?
| | Histocompatibility Antigens Class II | 4 | 1999 | 362 | 0.200 |
Why?
| | Down-Regulation | 3 | 2010 | 636 | 0.200 |
Why?
| | Cell Line | 7 | 2015 | 2781 | 0.200 |
Why?
| | Jurkat Cells | 6 | 2009 | 134 | 0.200 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2004 | 821 | 0.190 |
Why?
| | Type C Phospholipases | 4 | 2003 | 72 | 0.190 |
Why?
| | Promoter Regions, Genetic | 4 | 2014 | 1207 | 0.190 |
Why?
| | Immunophenotyping | 5 | 2016 | 311 | 0.190 |
Why?
| | NF-kappa B | 2 | 2021 | 653 | 0.190 |
Why?
| | Male | 16 | 2021 | 63681 | 0.190 |
Why?
| | CD3 Complex | 2 | 2009 | 103 | 0.180 |
Why?
| | H-2 Antigens | 3 | 2014 | 115 | 0.180 |
Why?
| | Stem Cells | 3 | 2001 | 577 | 0.180 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 390 | 0.180 |
Why?
| | Polymerase Chain Reaction | 4 | 2017 | 1038 | 0.180 |
Why?
| | Receptors, Immunologic | 1 | 2002 | 216 | 0.180 |
Why?
| | Hematopoiesis | 4 | 2010 | 183 | 0.180 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 3 | 2016 | 18 | 0.170 |
Why?
| | Tacrolimus | 1 | 2001 | 193 | 0.170 |
Why?
| | Hematopoietic Stem Cells | 4 | 1999 | 381 | 0.170 |
Why?
| | Rhadinovirus | 1 | 2020 | 20 | 0.170 |
Why?
| | History, 21st Century | 2 | 2012 | 183 | 0.170 |
Why?
| | Protein Binding | 6 | 2018 | 2121 | 0.160 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 4 | 2016 | 88 | 0.160 |
Why?
| | History, 20th Century | 2 | 2012 | 291 | 0.160 |
Why?
| | Immunoconjugates | 1 | 2001 | 103 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2000 | 399 | 0.160 |
Why?
| | Spleen | 4 | 2014 | 507 | 0.160 |
Why?
| | Cricetinae | 3 | 2015 | 277 | 0.160 |
Why?
| | Receptors, Cytokine | 1 | 1999 | 35 | 0.160 |
Why?
| | Sea Urchins | 2 | 1998 | 7 | 0.160 |
Why?
| | Blood Proteins | 1 | 2001 | 242 | 0.150 |
Why?
| | Interleukin-33 | 1 | 2019 | 48 | 0.150 |
Why?
| | Hepatocyte Nuclear Factor 1-alpha | 2 | 2015 | 16 | 0.150 |
Why?
| | Chronic Disease | 1 | 2024 | 1720 | 0.150 |
Why?
| | DNA-Binding Proteins | 5 | 2006 | 1443 | 0.140 |
Why?
| | DNA | 3 | 2021 | 1400 | 0.140 |
Why?
| | Base Sequence | 6 | 1997 | 2142 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 6 | 2001 | 643 | 0.140 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 132 | 0.140 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily C | 1 | 2016 | 8 | 0.140 |
Why?
| | Virus Replication | 1 | 2020 | 451 | 0.140 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1997 | 63 | 0.140 |
Why?
| | Peptide Fragments | 4 | 1997 | 692 | 0.130 |
Why?
| | Phenotype | 5 | 2006 | 3076 | 0.130 |
Why?
| | Clonal Deletion | 4 | 2001 | 16 | 0.130 |
Why?
| | Lymph Nodes | 2 | 2014 | 472 | 0.130 |
Why?
| | Mutation | 5 | 2013 | 3717 | 0.130 |
Why?
| | Hematopoietic System | 1 | 1996 | 8 | 0.130 |
Why?
| | Methylation | 2 | 2014 | 230 | 0.130 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 310 | 0.130 |
Why?
| | Biomarkers | 4 | 2024 | 3973 | 0.130 |
Why?
| | Mass Spectrometry | 1 | 2019 | 716 | 0.130 |
Why?
| | Binding Sites | 7 | 2013 | 1252 | 0.130 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 495 | 0.130 |
Why?
| | Chemokine CCL20 | 1 | 2015 | 5 | 0.130 |
Why?
| | Chemokine CXCL11 | 1 | 2015 | 3 | 0.130 |
Why?
| | Lymphoid Tissue | 1 | 1996 | 67 | 0.130 |
Why?
| | Introns | 1 | 1997 | 251 | 0.120 |
Why?
| | Receptors, Interleukin-7 | 3 | 2001 | 27 | 0.120 |
Why?
| | Exons | 1 | 1997 | 342 | 0.120 |
Why?
| | Germinal Center | 1 | 2015 | 57 | 0.120 |
Why?
| | Interferon Type I | 1 | 2016 | 139 | 0.120 |
Why?
| | Female | 15 | 2021 | 68776 | 0.120 |
Why?
| | Protein Structure, Tertiary | 4 | 2013 | 840 | 0.120 |
Why?
| | Th17 Cells | 1 | 2015 | 83 | 0.120 |
Why?
| | Oligopeptides | 1 | 1996 | 257 | 0.120 |
Why?
| | Cell Survival | 3 | 2014 | 1086 | 0.120 |
Why?
| | Animal Structures | 1 | 2014 | 9 | 0.110 |
Why?
| | beta 2-Microglobulin | 1 | 2014 | 49 | 0.110 |
Why?
| | Spodoptera | 3 | 2010 | 37 | 0.110 |
Why?
| | Transfection | 4 | 2001 | 911 | 0.110 |
Why?
| | Cell Movement | 2 | 2013 | 945 | 0.110 |
Why?
| | Prion Diseases | 1 | 1994 | 16 | 0.110 |
Why?
| | Histone Deacetylase 2 | 1 | 2013 | 10 | 0.110 |
Why?
| | Cytochrome c Group | 4 | 2002 | 42 | 0.110 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2013 | 28 | 0.110 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2014 | 63 | 0.110 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 82 | 0.110 |
Why?
| | Cell Migration Inhibition | 1 | 2013 | 16 | 0.100 |
Why?
| | Resting Phase, Cell Cycle | 2 | 2010 | 15 | 0.100 |
Why?
| | High Mobility Group Proteins | 1 | 2013 | 42 | 0.100 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 298 | 0.100 |
Why?
| | Lymphocyte Subsets | 1 | 2013 | 84 | 0.100 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2013 | 126 | 0.100 |
Why?
| | Animals, Newborn | 3 | 2006 | 835 | 0.100 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2013 | 125 | 0.090 |
Why?
| | Histones | 2 | 2014 | 588 | 0.090 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 185 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 587 | 0.090 |
Why?
| | Transcription, Genetic | 4 | 2015 | 1418 | 0.090 |
Why?
| | Acute Disease | 1 | 2014 | 980 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2000 | 1092 | 0.090 |
Why?
| | Autoantigens | 2 | 2013 | 417 | 0.090 |
Why?
| | Kinetics | 4 | 2013 | 1642 | 0.090 |
Why?
| | Transplantation Chimera | 1 | 2010 | 54 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 148 | 0.090 |
Why?
| | Isoenzymes | 2 | 2002 | 302 | 0.080 |
Why?
| | Alleles | 2 | 1990 | 845 | 0.080 |
Why?
| | Mitosis | 1 | 2011 | 180 | 0.080 |
Why?
| | Interferon-beta | 1 | 2010 | 89 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2002 | 312 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2009 | 3215 | 0.080 |
Why?
| | Phosphotyrosine | 2 | 2001 | 36 | 0.080 |
Why?
| | Transcription Factors, TFII | 1 | 2009 | 40 | 0.080 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2012 | 375 | 0.080 |
Why?
| | Immunoglobulin Class Switching | 1 | 2009 | 19 | 0.080 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2010 | 99 | 0.080 |
Why?
| | T-Lymphocytes, Cytotoxic | 3 | 1996 | 169 | 0.080 |
Why?
| | DNA, Complementary | 4 | 2001 | 270 | 0.080 |
Why?
| | Rats | 2 | 2014 | 5500 | 0.080 |
Why?
| | Herpesvirus 2, Human | 1 | 2009 | 28 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 194 | 0.080 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 52 | 0.080 |
Why?
| | Xenopus Proteins | 2 | 2006 | 35 | 0.080 |
Why?
| | GPI-Linked Proteins | 1 | 2009 | 68 | 0.080 |
Why?
| | Societies, Medical | 1 | 2012 | 751 | 0.080 |
Why?
| | Structure-Activity Relationship | 2 | 2001 | 548 | 0.070 |
Why?
| | Genes | 1 | 1988 | 226 | 0.070 |
Why?
| | STAT Transcription Factors | 1 | 2008 | 14 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 257 | 0.070 |
Why?
| | Atrophy | 1 | 2008 | 171 | 0.070 |
Why?
| | STAT5 Transcription Factor | 1 | 2008 | 48 | 0.070 |
Why?
| | Herpes Simplex | 1 | 2009 | 93 | 0.070 |
Why?
| | Organ Culture Techniques | 2 | 2001 | 154 | 0.070 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 1997 | 22 | 0.070 |
Why?
| | Herpesvirus 1, Human | 1 | 2009 | 86 | 0.070 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2009 | 153 | 0.070 |
Why?
| | Conserved Sequence | 3 | 1998 | 227 | 0.070 |
Why?
| | CD5 Antigens | 2 | 2002 | 9 | 0.070 |
Why?
| | Tissue Donors | 1 | 2010 | 391 | 0.070 |
Why?
| | Mice, Inbred C3H | 2 | 1999 | 273 | 0.070 |
Why?
| | CTLA-4 Antigen | 2 | 2013 | 87 | 0.070 |
Why?
| | Clone Cells | 2 | 2001 | 261 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 199 | 0.070 |
Why?
| | HeLa Cells | 1 | 2009 | 608 | 0.070 |
Why?
| | Severe Combined Immunodeficiency | 2 | 1997 | 20 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4063 | 0.070 |
Why?
| | Antigens, Surface | 2 | 2014 | 151 | 0.070 |
Why?
| | Disease Susceptibility | 1 | 2008 | 333 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 287 | 0.070 |
Why?
| | Time Factors | 4 | 2010 | 6556 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 833 | 0.070 |
Why?
| | Macromolecular Substances | 2 | 2001 | 213 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1997 | 361 | 0.060 |
Why?
| | Bone Marrow Cells | 3 | 2014 | 300 | 0.060 |
Why?
| | Hyaluronan Receptors | 1 | 2006 | 96 | 0.060 |
Why?
| | Mice, Inbred BALB C | 5 | 2016 | 1245 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2635 | 0.060 |
Why?
| | Transcriptome | 1 | 2012 | 887 | 0.060 |
Why?
| | Immunity, Innate | 2 | 2013 | 804 | 0.060 |
Why?
| | RNA, Messenger | 4 | 1998 | 2708 | 0.060 |
Why?
| | Lysine | 2 | 2014 | 286 | 0.060 |
Why?
| | Lectins, C-Type | 2 | 2016 | 71 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 68 | 0.060 |
Why?
| | Genetic Variation | 1 | 1990 | 937 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 79 | 0.060 |
Why?
| | Protein Conformation | 3 | 2000 | 859 | 0.060 |
Why?
| | Alternative Splicing | 2 | 1997 | 218 | 0.060 |
Why?
| | Molecular Structure | 1 | 2005 | 482 | 0.050 |
Why?
| | Point Mutation | 2 | 2010 | 225 | 0.050 |
Why?
| | Leukosialin | 2 | 2009 | 14 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 2 | 2005 | 638 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1085 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 153 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2005 | 431 | 0.050 |
Why?
| | Signaling Lymphocytic Activation Molecule Family | 1 | 2002 | 5 | 0.050 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2002 | 82 | 0.050 |
Why?
| | Genes, T-Cell Receptor | 1 | 2002 | 9 | 0.050 |
Why?
| | Hybridomas | 2 | 2000 | 234 | 0.050 |
Why?
| | Fas Ligand Protein | 1 | 2002 | 58 | 0.050 |
Why?
| | ZAP-70 Protein-Tyrosine Kinase | 1 | 2001 | 10 | 0.050 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2001 | 8 | 0.050 |
Why?
| | Antigen-Presenting Cells | 1 | 2002 | 150 | 0.050 |
Why?
| | Cysteine | 2 | 2001 | 195 | 0.050 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 196 | 0.050 |
Why?
| | Fetus | 2 | 2012 | 773 | 0.050 |
Why?
| | Transgenes | 1 | 2002 | 177 | 0.050 |
Why?
| | Dimerization | 1 | 2001 | 192 | 0.050 |
Why?
| | Embryo, Nonmammalian | 2 | 2001 | 166 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2001 | 213 | 0.050 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 15 | 0.050 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2001 | 131 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2001 | 267 | 0.040 |
Why?
| | Abatacept | 1 | 2001 | 46 | 0.040 |
Why?
| | Injections, Intralymphatic | 1 | 2000 | 1 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 2001 | 205 | 0.040 |
Why?
| | Mice, Congenic | 1 | 2000 | 22 | 0.040 |
Why?
| | Cell Division | 2 | 2000 | 797 | 0.040 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2001 | 39 | 0.040 |
Why?
| | Stromal Cells | 1 | 2001 | 107 | 0.040 |
Why?
| | Calcium Signaling | 1 | 2003 | 250 | 0.040 |
Why?
| | Embryonic and Fetal Development | 1 | 2000 | 94 | 0.040 |
Why?
| | Androstadienes | 1 | 2001 | 106 | 0.040 |
Why?
| | Granulocytes | 1 | 2000 | 77 | 0.040 |
Why?
| | Enzyme Inhibitors | 2 | 2001 | 827 | 0.040 |
Why?
| | Synovial Fluid | 1 | 2000 | 66 | 0.040 |
Why?
| | Interphase | 1 | 1999 | 31 | 0.040 |
Why?
| | Detergents | 1 | 2000 | 44 | 0.040 |
Why?
| | Cell Line, Transformed | 2 | 1999 | 141 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2001 | 282 | 0.040 |
Why?
| | Leukopoiesis | 1 | 1999 | 11 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 1999 | 33 | 0.040 |
Why?
| | Immune Tolerance | 2 | 1994 | 355 | 0.040 |
Why?
| | Stem Cell Factor | 1 | 1999 | 15 | 0.040 |
Why?
| | Bone Marrow Transplantation | 1 | 2000 | 274 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 265 | 0.040 |
Why?
| | Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1998 | 8 | 0.040 |
Why?
| | Chemokines, CXC | 1 | 1999 | 70 | 0.040 |
Why?
| | Interleukin-7 | 1 | 1999 | 59 | 0.040 |
Why?
| | Chemokine CXCL12 | 1 | 1999 | 79 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2001 | 237 | 0.040 |
Why?
| | Tumor Cells, Cultured | 2 | 1999 | 940 | 0.040 |
Why?
| | Biological Transport | 1 | 1999 | 401 | 0.040 |
Why?
| | Cricetulus | 2 | 2013 | 107 | 0.040 |
Why?
| | Ion Transport | 1 | 1998 | 62 | 0.040 |
Why?
| | Hyalin | 1 | 1998 | 7 | 0.040 |
Why?
| | Gene Rearrangement | 1 | 1999 | 148 | 0.040 |
Why?
| | Vanadates | 1 | 1997 | 14 | 0.040 |
Why?
| | Phosphopeptides | 1 | 1997 | 18 | 0.040 |
Why?
| | Selection, Genetic | 2 | 1989 | 249 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 1997 | 148 | 0.040 |
Why?
| | Antibodies, Monoclonal | 3 | 1999 | 1367 | 0.030 |
Why?
| | Receptors, Interleukin-2 | 2 | 1999 | 66 | 0.030 |
Why?
| | Molecular Weight | 2 | 1999 | 332 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 1997 | 1304 | 0.030 |
Why?
| | Receptor, EphB6 | 1 | 1996 | 1 | 0.030 |
Why?
| | Antigens, Neoplasm | 1 | 1999 | 309 | 0.030 |
Why?
| | Gene Deletion | 2 | 1999 | 379 | 0.030 |
Why?
| | Receptors, Interleukin | 1 | 1996 | 43 | 0.030 |
Why?
| | Agammaglobulinemia | 1 | 1996 | 33 | 0.030 |
Why?
| | Homozygote | 1 | 1997 | 193 | 0.030 |
Why?
| | Enzyme Induction | 1 | 1996 | 90 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 1996 | 59 | 0.030 |
Why?
| | Mice, SCID | 2 | 2013 | 351 | 0.030 |
Why?
| | Poly I-C | 1 | 2016 | 62 | 0.030 |
Why?
| | Chickens | 1 | 1996 | 188 | 0.030 |
Why?
| | Blotting, Western | 2 | 2013 | 1205 | 0.030 |
Why?
| | Receptors, CXCR5 | 1 | 2015 | 20 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 743 | 0.030 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 82 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1995 | 524 | 0.030 |
Why?
| | Gene Targeting | 1 | 1995 | 82 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 142 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1996 | 332 | 0.030 |
Why?
| | Organ Specificity | 1 | 1996 | 296 | 0.030 |
Why?
| | Sialoglycoproteins | 1 | 1995 | 155 | 0.030 |
Why?
| | Feedback, Physiological | 1 | 2015 | 77 | 0.030 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2015 | 17 | 0.030 |
Why?
| | Consensus Sequence | 1 | 1995 | 72 | 0.030 |
Why?
| | Ovum | 1 | 1995 | 29 | 0.030 |
Why?
| | Ribonucleases | 1 | 1995 | 54 | 0.030 |
Why?
| | Lasers | 1 | 1995 | 132 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 1997 | 455 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2014 | 44 | 0.030 |
Why?
| | Stochastic Processes | 1 | 1994 | 67 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 1999 | 853 | 0.030 |
Why?
| | Epitopes | 1 | 1996 | 470 | 0.030 |
Why?
| | Dendritic Cells | 2 | 2015 | 478 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 1995 | 275 | 0.030 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1994 | 21 | 0.030 |
Why?
| | Scrapie | 1 | 1994 | 4 | 0.030 |
Why?
| | PrPSc Proteins | 1 | 1994 | 9 | 0.030 |
Why?
| | CD4-CD8 Ratio | 1 | 1994 | 22 | 0.030 |
Why?
| | Viral Proteins | 1 | 1996 | 328 | 0.030 |
Why?
| | DNA Primers | 1 | 1995 | 510 | 0.030 |
Why?
| | Middle Aged | 2 | 2009 | 31154 | 0.030 |
Why?
| | Sf9 Cells | 1 | 2013 | 9 | 0.030 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1995 | 168 | 0.030 |
Why?
| | Deuterium Exchange Measurement | 1 | 2013 | 29 | 0.030 |
Why?
| | Prions | 1 | 1994 | 46 | 0.030 |
Why?
| | CHO Cells | 1 | 2013 | 153 | 0.030 |
Why?
| | Natural Cytotoxicity Triggering Receptor 1 | 1 | 2013 | 2 | 0.030 |
Why?
| | SOXC Transcription Factors | 1 | 2013 | 4 | 0.030 |
Why?
| | Interferons | 1 | 2015 | 194 | 0.030 |
Why?
| | Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 6 | 0.030 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2013 | 12 | 0.030 |
Why?
| | Biocatalysis | 1 | 2013 | 68 | 0.030 |
Why?
| | Genes, abl | 1 | 1993 | 3 | 0.030 |
Why?
| | Genes, src | 1 | 1993 | 5 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2013 | 44 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 316 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 1997 | 466 | 0.030 |
Why?
| | Adult | 2 | 2009 | 35576 | 0.020 |
Why?
| | Young Adult | 1 | 2009 | 12426 | 0.020 |
Why?
| | CD24 Antigen | 1 | 2012 | 20 | 0.020 |
Why?
| | Macrophages | 1 | 2000 | 1480 | 0.020 |
Why?
| | Tissue Distribution | 1 | 1993 | 315 | 0.020 |
Why?
| | Models, Molecular | 2 | 2013 | 1492 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 352 | 0.020 |
Why?
| | Haplotypes | 1 | 1994 | 475 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2013 | 588 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2012 | 189 | 0.020 |
Why?
| | Interleukins | 1 | 2013 | 241 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2013 | 366 | 0.020 |
Why?
| | Peptides | 2 | 1996 | 925 | 0.020 |
Why?
| | Precipitin Tests | 2 | 2001 | 94 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 284 | 0.020 |
Why?
| | Pichinde virus | 1 | 2010 | 1 | 0.020 |
Why?
| | H-Y Antigen | 1 | 2010 | 7 | 0.020 |
Why?
| | Mitogens | 1 | 2010 | 58 | 0.020 |
Why?
| | K562 Cells | 1 | 2010 | 86 | 0.020 |
Why?
| | Bystander Effect | 1 | 2010 | 15 | 0.020 |
Why?
| | Baculoviridae | 1 | 2010 | 44 | 0.020 |
Why?
| | Cell Polarity | 1 | 2011 | 140 | 0.020 |
Why?
| | Autoantibodies | 2 | 2015 | 1466 | 0.020 |
Why?
| | Adolescent | 1 | 2009 | 20393 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2010 | 141 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 1989 | 51 | 0.020 |
Why?
| | Genes, fos | 1 | 2009 | 33 | 0.020 |
Why?
| | Proteins | 1 | 1995 | 942 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1992 | 388 | 0.020 |
Why?
| | Pseudogenes | 1 | 1988 | 18 | 0.020 |
Why?
| | Blotting, Southern | 1 | 1988 | 69 | 0.020 |
Why?
| | Species Specificity | 1 | 1990 | 575 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2010 | 312 | 0.020 |
Why?
| | Mycobacterium tuberculosis | 1 | 2012 | 308 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2000 | 7086 | 0.020 |
Why?
| | Age Factors | 2 | 2012 | 3144 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 1988 | 406 | 0.020 |
Why?
| | MicroRNAs | 1 | 2014 | 678 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 1990 | 640 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1198 | 0.020 |
Why?
| | Brain | 1 | 1996 | 2679 | 0.010 |
Why?
| | Lung | 1 | 2016 | 3930 | 0.010 |
Why?
| | Aging | 1 | 1993 | 1776 | 0.010 |
Why?
| | Subtilisins | 1 | 2001 | 10 | 0.010 |
Why?
| | Furin | 1 | 2001 | 13 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 2001 | 77 | 0.010 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2001 | 38 | 0.010 |
Why?
| | Xenopus | 1 | 2001 | 86 | 0.010 |
Why?
| | Aged | 1 | 2000 | 22103 | 0.010 |
Why?
| | Glycosylphosphatidylinositols | 1 | 1999 | 11 | 0.010 |
Why?
| | Cell Aggregation | 1 | 1999 | 26 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1999 | 149 | 0.010 |
Why?
| | Lymphoma, T-Cell | 1 | 1999 | 23 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1999 | 74 | 0.010 |
Why?
| | Genes, RAG-1 | 1 | 1998 | 12 | 0.010 |
Why?
| | Hydroxamic Acids | 1 | 1998 | 88 | 0.010 |
Why?
| | Cell Death | 1 | 1999 | 354 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1998 | 111 | 0.010 |
Why?
| | Ectoderm | 1 | 1998 | 50 | 0.010 |
Why?
| | Histone Deacetylases | 1 | 1998 | 212 | 0.010 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 1998 | 209 | 0.010 |
Why?
| | Receptor Aggregation | 1 | 1996 | 10 | 0.010 |
Why?
| | Receptors, Interleukin-4 | 1 | 1996 | 15 | 0.010 |
Why?
| | Immunologic Techniques | 1 | 1996 | 39 | 0.010 |
Why?
| | Janus Kinase 1 | 1 | 1996 | 24 | 0.010 |
Why?
| | Cell Adhesion | 1 | 1998 | 452 | 0.010 |
Why?
| | Proline | 1 | 1997 | 76 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1996 | 206 | 0.010 |
Why?
| | Ovary | 1 | 1998 | 210 | 0.010 |
Why?
| | Vaccines, Synthetic | 1 | 1996 | 126 | 0.010 |
Why?
| | Rosaniline Dyes | 1 | 1995 | 12 | 0.010 |
Why?
| | GRB2 Adaptor Protein | 1 | 1995 | 13 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 1995 | 12 | 0.010 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 42 | 0.010 |
Why?
| | Coloring Agents | 1 | 1995 | 77 | 0.010 |
Why?
| | Photochemistry | 1 | 1995 | 132 | 0.010 |
Why?
| | Chromatin | 1 | 1998 | 479 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 1999 | 1698 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1997 | 539 | 0.010 |
Why?
| | Immunization, Passive | 1 | 1994 | 87 | 0.010 |
Why?
| | DNA Methylation | 1 | 1998 | 607 | 0.010 |
Why?
| | Nucleocapsid Proteins | 1 | 1992 | 25 | 0.010 |
Why?
| | Viral Core Proteins | 1 | 1992 | 21 | 0.010 |
Why?
| | Nucleoproteins | 1 | 1992 | 28 | 0.010 |
Why?
| | Escherichia coli | 1 | 1997 | 774 | 0.010 |
Why?
| | RNA | 1 | 1998 | 883 | 0.010 |
Why?
| | ErbB Receptors | 1 | 1995 | 607 | 0.010 |
Why?
| | Immunization | 1 | 1992 | 411 | 0.010 |
Why?
| | Histocompatibility Antigens | 1 | 1989 | 107 | 0.000 |
Why?
|
|
Berg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|